An earlier meta-analysis of tumor markers in GC discovered that overall positivity rates for all these markers were low (CEA 24.0%, CA-199 27.0%, CA724 29.9%), and even lower in stage I GC (CEA 13.7%, CA199 9.0%, CA724 12.0%) (31). The gene discussed is CEACAM5; the disease is gastric cancer.